Effectiveness of osteoporosis medication on site-specific fracture-risk attenuation among adults with epilepsy.

Published in: Epilepsia (2020)

Osteoporosis medication is associated with a clinically meaningful 12-month NTFx risk attenuation for adults with epilepsy, especially for those just starting osteoporosis medication.

Keyphrases

postmenopausal women
bone mineral density
healthcare
adverse drug
randomized controlled trial
systematic review
emergency department